Stem Cell Banking Market Research Report - Global Forecast till 2025

Stem Cell Banking Market Research Report - Global Forecast till 2025

ID: MRFR/HC/6969-HCR | November, 2019 | Region: Global | 90 pages | Half-Cooked Research Reports

Market Forecast


Stem Cell Banking Market is expected to hold a value of USD 12,056.7 Million by 2025 at a CAGR of 9.8%.


Market Synopsis


Worldwide rising incidence of life-threatening genetic disorders and chronic diseases is expected to foster market growth during the forecast period. According to the statistics published by Genetics Home Reference, about one in 200,000 individuals in the US are born with syndrome A every year. An estimated 15,000 infants with syndrome B were born in 2018 across the world. In addition, about six in 10 adults in the US have a chronic disease, and four in 10 adults in the US have two or more chronic diseases.


Market Influencer


Increased spending on the management of chronic diseases is likely to act as a promising factor for market growth in the near future. The Centers for Disease Control and Prevention (CDC) reported that in the US, USD 3.3 trillion (90% of the total health expenditure) was spent on chronic and mental health conditions during 2018.


Market Drivers



  • Worldwide surging newborn population

  • Growing awareness about stem cell therapeutics

  • Mounting development of novel technologies for stem cell preservation, processing, and storage

  • Increasing mergers and acquisitions by prominent players in the market. For instance, in June 2018, AMAG Pharmaceuticals, Inc. entered into a definitive agreement to divest Cord Blood Registry to GI Partners, a San Francisco-based private equity investment firm, to extend the combined GI Partners’ capabilities internationally

  • Rising investments in stem cell research


Market Restraints



  • High operational and storage costs

  • Lack of awareness about stem cell banking in developing and underdeveloped countries


Segmentation


By Cell Type




  • Umbilical Cord Stem Cells: Expected to command the market owing to the higher adoption of umbilical cord stem cells to treat around 80 diseases. This segment has been additionally classified into cord blood, cord tissue, and placenta. Worldwide growth in the number of placental and cord banks (particularly in the US and Europe) along with rising awareness about the therapeutic potential of stem cells is likely to support the considerable growth of the placenta segment.




  • Adult Stem Cells: Adult stem cells originate from adult tissue and redevelop into all the cell types of the organ from the origin.




  • Embryonic Stem Cells: Embryonic stem cells or pluripotent stem cells are produced from the inner cell mass of a blastocyst (embryo)




By Bank Type




  • Private Banks: This is anticipated to be the largest segment attributed to higher revenue generation from the superior service offering




  • Public Banks: Public cord blood banking is the act of donating the baby's cord blood to be used by a family in need. The cost of preserving cord blood is free at public banks.




  • Hybrid Banks: Few private cord blood banks also operate a public donation program where costs for these programs are mostly covered in part by the private side of the business. These banks are called hybrid banks.




By Application




  • Thalassemia: Expected to witness modest market growth.




  • Cerebral Palsy: Likely to hold the highest revenue share from 2019 to 2025 due to rising clinical and research applications of stem cell banking. In 2010, Dr. Kurtzberg conducted first trial on the safety and feasibility of cord blood for the treatment of acquired neurological disorders such as cerebral palsy.




  • Diabetes: Stem cell treatment can be used for both type 1 and type 2 diabetes and prevent diabetes-related complications such as heart disease, blindness, kidney failure and amputation of limbs.




  • Leukemia: A stem cell transplant can be used to restore healthy bone marrow in patients with leukemia. Stem cells help stimulate new bone marrow growth and restore the immune system.




  • Autism: In June 2014, Duke University Medicine was awarded USD 15 million to support an innovative research program to explore the use of umbilical cord blood cells to treat autism, stroke, cerebral palsy, and related brain disorders. On the contrary, the US Food and Drug Administration (FDA) has approved the use of stem cells for blood disorders, including cancer, but not for autism currently.




  • Others: This segment comprises acquired hearing loss, stroke, brain disorders, sickle cell disease, heart diseases, multiple sclerosis, Alzheimer's disease, Wiskott-Aldrich syndrome, etc.




By Region




  • Americas: The largest regional market. The presence of major market participants in the US, ongoing approval of stem cell lines for disease treatment, and increasing awareness among citizens about stem cell banking is about to nourish the dominance of the Americas throughout the forecast period.




  • Europe: The presence of initiatives implemented by the European Union and various organizations would augment the demand for cord blood banking. Furthermore, uniform regulations implemented by the European government about the support of voluntary and free donations, procedures to standardize the testing of donated tissues and cells, and procedures to ensure document safety and traceability would support the regional market growth over the study period.




  • Asia-Pacific: This region is anticipated to register comparatively higher CAGR over the assessment period attributed to rapidly developing medical infrastructure, growing older population along with as surge in prevalence of chronic diseases, and rising per capita healthcare expenditure in India, China, and Japan.




  • Middle East & Africa: The smallest market due to limited healthcare infrastructure and limited exposure to technological advancements.




Key Players



  • CBR Systems, Inc. (US)

  • Cryo-Cell International, Inc. (US)

  • Cordlife (Singapore)

  • Cryo-Save AG (Netherlands)

  • Global Cord Blood Corporation (Hong Kong)

  • Americord Registry LLC (US)

  • Smart Cells International Ltd. (UK)

  • Celgene Corporation (US)

  • BrainStorm Cell Therapeutics (US)

  • Regrow Biosciences Pvt. Ltd. (India)

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Stem Cell Banking Market, by Cell Type

1.1.2. Global Stem Cell Banking Market, by Bank Type

1.1.3. Global Stem Cell Banking Market, by Application

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL STEM CELL BANKING MARKET, BY CELL TYPE

6.1. Overview

6.2. Umbilical Cord Stem Cells

6.2.1. Cord Blood

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.2.1. Cord Tissue

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.2.1. Placenta

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3. Adult Stem Cells

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.4. Embryonic Stem Cells

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7. GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE

7.1. Overview

7.2. Private Banks

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.3. Public Banks

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.4. Hybrid Banks

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8. GLOBAL STEM CELL BANKING MARKET, BY APPLICATION

8.1. Overview

8.2. Thalassemia

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.3. Cerebral Palsy

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4. Diabetes

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.5. Leukemia

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.6. Autism

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.7. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9. GLOBAL STEM CELL BANKING MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitor Dashboard

10.3. Major Growth Strategies in the Stem Cell Banking Market

10.4. Competitive Benchmarking

10.5. The Leading Players in terms of Number of Developments in the Stem Cell Banking Market

10.6. Key Developments & Growth Strategies

10.7. Major Market Players Financial Matrix & Market Ratio

11. COMPANY PROFILES

11.1. CBR Systems, Inc.

11.1.1. Company Overview

11.1.2. Products/Services Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Cryo-Cell International, Inc.

11.3. Cordlife

11.4. Cryo-Save AG

11.5. Global Cord Blood Corporation

11.6. Americord Registry LLC

11.7. Smart Cells International Ltd

11.8. Celgene Corporation

11.9. BrainStorm Cell Therapeutics

11.10. Regrow Biosciences Pvt. Ltd

12. APPENDIX

12.1. References

12.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL STEM CELL BANKING MARKET SYNOPSIS, 2019–2025

TABLE 2 GLOBAL STEM CELL BANKING MARKET ESTIMATES & FORECAST, 2019–2025 (USD MILLION)

TABLE 3 GLOBAL STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 4 GLOBAL STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 5 GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 6 GLOBAL STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 7 GLOBAL STEM CELL BANKING MARKET, BY REGION, 2019–2025 (USD MILLION)

TABLE 8 NORTH AMERICA: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 9 NORTH AMERICA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 10 NORTH AMERICA: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 11 NORTH AMERICA: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 12 US: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 13 US: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 14 US: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 15 US: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 16 CANADA: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 17 CANADA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 18 CANADA: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 19 CANADA: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 20 LATIN AMERICA: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 21 LATIN AMERICA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 22 LATIN AMERICA: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 23 LATIN AMERICA: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 24 EUROPE: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 25 EUROPE: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 26 EUROPE: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 27 EUROPE: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 28 WESTERN EUROPE: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 29 WESTERN EUROPE: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 30 WESTERN EUROPE: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 31 WESTERN EUROPE: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 32 EASTERN EUROPE: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 33 EASTERN EUROPE: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 34 EASTERN EUROPE: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 35 EASTERN EUROPE: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 36 ASIA-PACIFIC: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 37 ASIA-PACIFIC: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 38 ASIA-PACIFIC: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 39 ASIA-PACIFIC: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET, BY CELL TYPE, 2019–2025 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2019–2025 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET, BY BANK TYPE, 2019–2025 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET, BY APPLICATION, 2019–2025 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL STEM CELL BANKING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL STEM CELL BANKING MARKET

FIGURE 4 GLOBAL STEM CELL BANKING MARKET SHARE, BY CELL TYPE, 2018 (%)

FIGURE 5 GLOBAL STEM CELL BANKING MARKET SHARE, BY BANK TYPE, 2018 (%)

FIGURE 6 GLOBAL STEM CELL BANKING MARKET SHARE, BY APPLICATION, 2018 (%)

FIGURE 7 GLOBAL STEM CELL BANKING MARKET SHARE, BY REGION, 2018 (%)

FIGURE 8 AMERICAS: STEM CELL BANKING MARKET SHARE BY REGION, 2018 (%)

FIGURE 9 NORTH AMERICA: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 10 EUROPE: STEM CELL BANKING MARKET SHARE, BY REGION, 2018 (%)

FIGURE 11 WESTERN EUROPE: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 12 ASIA-PACIFIC: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 13 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 14 GLOBAL STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS, 2018 (%)

FIGURE 15 CBR SYSTEMS, INC.: KEY FINANCIALS

FIGURE 16 CBR SYSTEMS, INC.: SEGMENTAL REVENUE

FIGURE 17 CBR SYSTEMS, INC.: REGIONAL REVENUE

FIGURE 18 CRYO-CELL INTERNATIONAL, INC.: KEY FINANCIALS

FIGURE 19 CRYO-CELL INTERNATIONAL, INC.: SEGMENTAL REVENUE

FIGURE 20 CRYO-CELL INTERNATIONAL, INC.: REGIONAL REVENUE

FIGURE 21 CORDLIFE: KEY FINANCIALS

FIGURE 22 CORDLIFE: SEGMENTAL REVENUE

FIGURE 23 CORDLIFE: REGIONAL REVENUE

FIGURE 24 CRYO-SAVE AG: KEY FINANCIALS

FIGURE 25 CRYO-SAVE AG: SEGMENTAL REVENUE

FIGURE 26 CRYO-SAVE AG: REGIONAL REVENUE

FIGURE 27 GLOBAL CORD BLOOD CORPORATION: KEY FINANCIALS

FIGURE 28 GLOBAL CORD BLOOD CORPORATION: SEGMENTAL REVENUE

FIGURE 29 GLOBAL CORD BLOOD CORPORATION: REGIONAL REVENUE

FIGURE 30 AMERICORD REGISTRY LLC: KEY FINANCIALS

FIGURE 31 AMERICORD REGISTRY LLC: SEGMENTAL REVENUE

FIGURE 32 AMERICORD REGISTRY LLC: REGIONAL REVENUE

FIGURE 33 SMART CELLS INTERNATIONAL LTD.: KEY FINANCIALS

FIGURE 34 SMART CELLS INTERNATIONAL LTD.: SEGMENTAL REVENUE

FIGURE 35 SMART CELLS INTERNATIONAL LTD.: REGIONAL REVENUE

FIGURE 36 CELGENE CORPORATION: KEY FINANCIALS

FIGURE 37 CELGENE CORPORATION: SEGMENTAL REVENUE

FIGURE 38 CELGENE CORPORATION: REGIONAL REVENUE

FIGURE 39 BRAINSTORM CELL THERAPEUTICS: KEY FINANCIALS

FIGURE 40 BRAINSTORM CELL THERAPEUTICS: SEGMENTAL REVENUE

FIGURE 41 BRAINSTORM CELL THERAPEUTICS: REGIONAL REVENUE

FIGURE 42 REGROW BIOSCIENCES PVT. LTD.: KEY FINANCIALS

FIGURE 43 REGROW BIOSCIENCES PVT. LTD.: SEGMENTAL REVENUE

FIGURE 44 REGROW BIOSCIENCES PVT. LTD.: REGIONAL REVENUE



This table of content is tentative and subject to change as the research progresses.

Please note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.